Alfred Yellson

Doctor of Medicine,  Mayo Clinic - Rochester 

Location: Africa

Consulting Services

Hospital-Pharmacy-Insurance Legal Support Career Advice and Mentoring IT-Web-Mobile Technology Grant Submission

Areas Of Interest

Natriuretic Peptides, Atrial Cardiomegaly, Exercise Induced End Stage Kidney Disease Congenital Diaphragmatic Hernias Intermittent Explosive Disorder Inter-Individual Biological Variations Eczematous Disorder Acidic Keratins Patient Health Questionnaire Gonadotropin Receptor, Chorionic Tumor Suppressing Gene Regions, Cingulate Aspartylphenylalanine Methyl Ester Amniotic Bands Urokinase Plasminogen Activator Receptors Erythrocyte Aggregations Four Dimensional CT Scan Electrophoresis, Starch Gel Pregnancy Associated alpha 2 Macroglobulins Traumatization, Vicarious Adenoma, Lactotroph Tibial Syndromes, Anterior Bromhexinratiopharm Therapies, Massage Compounds, Diazonium Type 1 Angiotensin Receptor Blockers Leucovorin, Calcium Rats, Zucker alpha Telomere Binding Protein Transmitter Uptake Inhibitors, Neuronal Blood Pressures, High Receptor, EphA5 Ids Antigen, AC133-2 Tirapazamine Immunoglobulin epsilon Chains

Professional Narrative

Dr. Alfred Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Executive Director, Mayo Clinic 2002
Medical Writer, Harvard Med 2018

Education

Doctor of medicine, Weill Medical College 2009
Bachelor of science in nursing, Yale School of Medicine 1993

Referees

Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02